Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AT-130 is a HBV virus inhibitor with improved potency (IC50 = 0.13 μM) and reduced toxicity in the HepAD38 cell line. AT-130 blocks HBV replication at the level of viral RNA packaging.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 67.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 313.00 | |
25 mg | In stock | $ 497.00 | |
50 mg | In stock | $ 723.00 | |
100 mg | In stock | $ 987.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 178.00 |
Description | AT-130 is a HBV virus inhibitor with improved potency (IC50 = 0.13 μM) and reduced toxicity in the HepAD38 cell line. AT-130 blocks HBV replication at the level of viral RNA packaging. |
Targets&IC50 | HBV:0.13 μM |
Synonyms | AT 130 |
Molecular Weight | 488.33 |
Formula | C22H22BrN3O5 |
CAS No. | 211364-06-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 23 mg/mL (47.09 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AT-130 211364-06-6 Cell Cycle/Checkpoint DNA Damage/DNA Repair Microbiology/Virology HBV DNA/RNA Synthesis RNA Huh-7 AT 130 rtM204I inhibit rtL180M Inhibitor Hepatitis B virus HepG2 core AT130 inhibitor